MiMedx outlines 2027 revenue well in excess of $400M with over 20% adjusted EBITDA margin following planned Sanara deal — See source for full details.
$MDXG
Price history, market instrument context, member research, and related headlines in one place.
MDXG key statistics
NasdaqCMUSD
52-week range
$3.0334%$7.97
Latest session $4.64–$4.74MiMedx Group, Inc. (MDXG) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $4.70, up $0.01 (0.21%) from the previous close of $4.69. It has traded between $4.64 and $4.74 in the latest session. Over the past year it has ranged from $3.03 to $7.97, leaving it in the lower half of its 52-week range (34%). Reported volume for the session was 1.6M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Earnings call transcript: MiMedx Q2 2026 revenue beats as loss widens — See source for full details.
Loading $MDXG research…